Janssen Products LP, doing business as Ortho Biotech Products, LP, was awarded a $22,685.43 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule managed by the Department of Veterans Affairs and General Services Administration. The delivery order, issued by the VA Veterans Health Administration Veterans Integrated Service Network 21, is for the antitubercular medication bedaquiline, also known as Sirturo, to treat multidrug-resistant tuberculosis in veterans. The firm...
This firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Janssen Products LP, a subsidiary of Johnson & Johnson, to provide the antitubercular drug Sirturo (bedaquiline) to VA medical facilities. The $22,685.43 award is part of Janssen's indefinite delivery vehicle under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple award contract potentially worth $881 million. The VA has also awarded...
Janssen Products LP has been awarded a $22,685.43 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract to provide SIRTURO 100MG tablets to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order has a completion date of May 26, 2023 and was awarded on March 27, 2023. It utilizes a firm fixed price contracting method and will be performed in Horsham, Pennsylvania. No...
Janssen Products LP, doing business as Ortho Biotech Products, LP, was awarded a $22,685.43 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) master contract vehicle. The order calls for Janssen to provide SIRTURO to the Veterans Health Administration Veterans Integrated Service Network 21, located in Horsham, Pennsylvania, with performance at that same location. No set-aside designation was used for this award to support the Veterans Affairs' mission of providing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $22,685 delivery order against the Janssen Products LP Pharmaceuticals and Drugs GSA Schedule to provide Sirturo 100mg tablets. As part of its mission to provide healthcare services to veterans, VA-VHA VISN 21 issued this order for the antituberculosis medication to likely treat patients within its region. Janssen will deliver the product to a facility in Horsham, Pennsylvania...
Janssen Products LP was awarded a $22,685 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for the delivery of Sirturo 100mg tablets to a location in Fresno, California by December 7, 2022. The contract utilizes Master Contract FSS-61-IB and has no set-aside designation. The delivery order will supply pharmaceutical products to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $22,685 delivery order to Janssen Products LP under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order, designated SITURO - 59676-0701-01, is for pharmaceutical products and has a completion date of April 28, 2023. The pricing is firm fixed price and performance will occur in Horsham, Pennsylvania. No set-aside provisions were applied to this order to...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, to provide the drug Uptravi. The contract has a ceiling value of $76,829.76 and an ultimate completion date of December 19, 2019. It was awarded on January 12, 2018 under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not have a small business set-aside designation....
Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., has been awarded a $17,642.95 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to provide BALVERSA 4 MG. The delivery order was placed against Janssen's multiple award GSA Schedule Pharmaceuticals and Drugs contract, also known as FSS-61-IB, which has no set-aside designation and expires in March 2024. As a manufacturer of pharmaceutical...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., to provide BALVERSA (erdafitinib), an oncology medication, to the VA's Veterans Health Administration (VHA). The $15,090.62 delivery order was issued on an emergency basis to the pharmaceutical manufacturer under a $3.7 million Blanket Purchase Agreement (BPA) established in 2020, which allows VHA buying offices to efficiently...